Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2010
12/30/2010US20100331423 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
12/30/2010US20100331422 Stable hydroalcoholic compositions
12/30/2010US20100331421 Disinfectant and/or bactericidal aqueous compositions
12/30/2010US20100331416 Use of Monochlorourea to Treat Industrial Waters
12/30/2010US20100331414 Crystal comprising (2r)-2-propyloctanoic acid and amine
12/30/2010US20100331409 Use of Methyl Cinnamate in the Inhibition of Candida Albicans Biofilms
12/30/2010US20100331404 Vector Delivery-Based Microbicides
12/30/2010US20100331401 Antimicrobial and antiinflammatory composition
12/30/2010US20100331398 Derives du gossypol et de l'apogossypol, leurs preparations et leurs applictions
12/30/2010US20100331397 2-5a analogs and their methods of use
12/30/2010US20100331394 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure
12/30/2010US20100331385 Pyrazole urea derivatives used as kinase inhibitors
12/30/2010US20100331383 Compounds for the treatment of aids and other viral diseases
12/30/2010US20100331370 Novel isobenzofuran analogs of sclerophytin A
12/30/2010US20100331368 2,5-diaryl selenophene compounds, aza 2,5-diaryl thiophene compounds, and their prodrugs as antiprotozoal agents
12/30/2010US20100331351 Methods and compositions for treating bacterial infection
12/30/2010US20100331337 Quercetin-Containing Compositions
12/30/2010US20100331331 Therapeutic compositions and the use thereof
12/30/2010US20100331318 Azatricyclic antibiotic compounds
12/30/2010US20100331315 Rhodanines and related heterocycles as kinase inhibitors
12/30/2010US20100331314 Pyrazolopyrimidines and related heterocycles as kinase inhibitors
12/30/2010US20100331313 Thiazole Derivatives as Protein Kinase Inhibitors
12/30/2010US20100331308 Oxazolidinone derivatives
12/30/2010US20100331283 Mitotic kinesin inhibitors and methods of use thereof
12/30/2010US20100331282 Pyridine derivative containing ((phosphonooxy)methyl)pyridinium ring, and antifungal agent containing these derivative
12/30/2010US20100331277 Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
12/30/2010US20100331242 Method of using lectins for prevention and treatment of oral and alimentary tract disorders
12/30/2010US20100331241 Bacteriocins and Novel Bacterial Strains
12/30/2010US20100331240 Methods for prevention and treatment of infections with supraphysiological doses of mannan-binding lectin (mbl) and ficolin-mbl fusion proteins
12/30/2010US20100331239 Cd14 and peptides thereof for protection of cells against cell death
12/30/2010US20100331236 Cyclic peptides as g-protein coupled receptor antagonists
12/30/2010US20100331234 Aminoalcohol lipidoids and uses thereof
12/30/2010US20100330613 Methods for determining efficacy of chemotherapeutic agents
12/30/2010US20100330211 Fucoidan compositions and methods for dietary and nutritional supplements
12/30/2010US20100330209 Hair growth stimulants adn the manufacturing method thereof
12/30/2010US20100330201 Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
12/30/2010US20100330196 Enhanced activity hydrogen peroxide disinfectant
12/30/2010US20100330173 Compounds and methods for treating influenza
12/30/2010US20100330165 Use of chemotherapeutic agents
12/30/2010US20100330162 Spray freeze dry of compositions for pulmonary adminstration
12/30/2010US20100330161 Oral delivery of tetanus toxoid
12/30/2010US20100330160 Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6
12/30/2010US20100330157 Biomaterial for the controlled delivery of ingredients
12/30/2010US20100330146 Contact lenses for extended release of bioactive agents containing diffusion attenuators
12/30/2010US20100330138 Biostable, multipurpose, microbicidal intravaginal devices
12/30/2010US20100330137 High bioavailability formulation of mangosteen and manufacturing process thereof
12/30/2010US20100330129 Gastroresistant Pharmaceutical Formulations Containing Rifaximin
12/30/2010US20100330125 Novel polysaccharide immunogens from clostridium difficile
12/30/2010US20100330124 Vaccine compositions and methods of use to protect against infectious disease
12/30/2010US20100330120 Human parainfluenza viruses having separated p and c genes
12/30/2010US20100330119 Chromatography medium, preparation method of the same, and method for producing virus vaccine using the chromatography medium
12/30/2010US20100330117 Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimers's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c
12/30/2010US20100330116 Live attenuated salmonella for use as vaccine
12/30/2010US20100330115 Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody
12/30/2010US20100330113 Vaccine Antigens
12/30/2010US20100330109 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
12/30/2010US20100330101 BIFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION
12/30/2010US20100330100 Pseudomonas aeruginosa-outer membrane protein pa4710
12/30/2010US20100330099 Stabilized anti-hepatitis b (hbv) antibody formulations
12/30/2010US20100330086 Cationic steroid antimicrobial compositions and methods of use
12/30/2010US20100330071 Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
12/30/2010US20100330068 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
12/30/2010US20100330067 Compounds and Methods for the Modulation of Toll-Like Receptor Function
12/30/2010US20100330061 Methods and Devices for Treating Lung Dysfunction
12/30/2010US20100330056 Enhanced generation of cytotoxic t-lymphocytes by il-21 mediated foxp3 suppression
12/30/2010US20100330054 Preparation, use of preparation for treatment, and method of treatment of intestinal infection
12/30/2010US20100330035 Pharmaceutical Compositions for Treatment of HCV Patients that are Poor-Responders to Interferon
12/30/2010US20100330032 Heterocyclic antiviral compounds
12/30/2010US20100330007 Imrpoved Skin Brightening Compositions
12/30/2010US20100330006 Antimicrobial lotion compositions
12/30/2010US20100330001 Antibacterial compositions
12/30/2010US20100329995 Compositions containing lactoferrin, and methods of using same to promote growth of skin cells
12/30/2010US20100329984 Respiratory dispersion for metered dose inhalers
12/29/2010WO2010151672A2 Amino acid derived ureas
12/29/2010WO2010151640A2 Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease
12/29/2010WO2010151526A1 Bispecific antibodies that bind to complement proteins
12/29/2010WO2010151495A2 Materials and methods for treating and preventing viral infections
12/29/2010WO2010151488A1 Combination of boceprevir with 5- ( { 6- [2, 4- bis (trifluoromethyl) phenyl] pyridazin-3 -yl } methyl) -2- (2 -fluorophenyl) -5h- imidazo [4, 5-c] pyridine for the treatment of hcv
12/29/2010WO2010151487A1 Combination of telaprevir with 5- ({6- [2,4-bis (trifluoromethyl) phenyl] pyridazin-3 -yl)methyl) -2- (2 -fluorophenyl) -5h- imidazo [4, 5-c]pyridine for the treatment of hcv
12/29/2010WO2010151472A1 Combination of a ns5b polymerase inhibitor and a hcv ns3 protease inhibitor for the treatment of hcv
12/29/2010WO2010151353A2 Injectable beta-hairpin peptide hydrogel that kills methicillin-resistant staphylococcus aureus
12/29/2010WO2010151076A2 Adjuvant composition comprising (poly-gamma-glutamate)-chitosan nanoparticles
12/29/2010WO2010150982A2 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same
12/29/2010WO2010150836A1 Enhancer of activity of nucleic acid analogue
12/29/2010WO2010150761A1 Pyridine derivative having ((phosphonooxy)methyl)pyridinium ring and anti-fungal agent comprising same
12/29/2010WO2010150281A2 Novel azabicyclohexanes
12/29/2010WO2010150100A1 The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
12/29/2010WO2010149980A2 Topical formulation containing a tetracycline and a method of treating skin infections using the same
12/29/2010WO2010149761A1 Composition for treatment of tuberculosis
12/29/2010WO2010149758A1 Antifungal 1, 2, 4-triazolyl derivatives
12/29/2010WO2010149459A1 Use of hat inhibitors and tmprss2 inhibitors as medicaments
12/29/2010WO2010149414A1 5-mercapto-[1, 2, 4] triazolylmethyl-cyclopentanol compounds and their agricultural and pharmaceutical uses
12/29/2010WO2010149016A1 New compound and use thereof
12/29/2010WO2010148963A1 Compounds having activity against hepatitis virus and use thereof
12/29/2010WO2010148632A1 Dihydropyridine compounds and preparation methods, pharmaceutical compositions and uses thereof
12/29/2010WO2010148631A1 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
12/29/2010WO2010148541A1 A immunogenic composition comprising peptides derived from cytomegalovirus and the use thereof
12/29/2010WO2010148511A1 Chimeric influenza virus-like particles comprising hemagglutinin
12/29/2010WO2010148496A1 Lipidated tumor- associated antigens and immunotherapeutic compositions
12/29/2010WO2010148434A1 Chimeric molecules
1 ... 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 ... 1798